SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 85 filers reported holding SEELOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,241,003 | -79.9% | 6,744,585 | +30.5% | 0.07% | -85.2% |
| Q2 2023 | $6,175,784 | +76.3% | 5,168,020 | +2.0% | 0.48% | +46.0% |
| Q1 2023 | $3,503,015 | +5.1% | 5,068,020 | +3.2% | 0.33% | +11.2% |
| Q4 2022 | $3,333,024 | -34.1% | 4,908,725 | 0.0% | 0.30% | -55.4% |
| Q3 2022 | $5,056,000 | +51.4% | 4,908,725 | 0.0% | 0.66% | +71.5% |
| Q2 2022 | $3,340,000 | -19.2% | 4,908,725 | -0.5% | 0.39% | +30.0% |
| Q1 2022 | $4,133,000 | +3.5% | 4,933,024 | +101.4% | 0.30% | -8.3% |
| Q4 2021 | $3,992,000 | -10.9% | 2,449,267 | +31.7% | 0.32% | -15.8% |
| Q3 2021 | $4,481,000 | -2.6% | 1,859,635 | +6.7% | 0.38% | -5.6% |
| Q2 2021 | $4,601,000 | -24.7% | 1,742,776 | +42.2% | 0.41% | -37.4% |
| Q1 2021 | $6,114,000 | – | 1,225,244 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 508,000 | $249,000 | 0.10% |
| 1492 Capital Management LLC | 150,000 | $74,000 | 0.09% |
| Uniplan Investment Counsel, Inc. | 2,069,121 | $1,014,000 | 0.08% |
| ARDSLEY ADVISORY PARTNERS LP | 70,000 | $34,000 | 0.01% |
| Spark Investment Management LLC | 35,210 | $17,000 | 0.01% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 191,000 | $94,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $15,000 | 0.00% |
| Procyon Advisors, LLC | 2,500 | $1,000 | 0.00% |
| Renaissance Technologies | 1,078,379 | $529,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |